Chronic Kidney Disease Trials in India

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1123 matching records held by the registry are in this view. Synced 20 Sep 2026, 03:16 UTC

1123

Studies in scope

all four open statuses

610

Recruiting now

open to new participants

222

Lead sponsors

across recruiting studies

Top sites

Ahmedabad 1 Bangalore 1 Belagavi 1 Bhubaneswar 1 Guntur 1

Narrow the registerReset

Search within results

Recruitment status

Phase

Lead sponsor

Clear sponsor filter

Site location

All 8 locations

Target enrolment

Status

Study

Lead sponsor

Phase

Enrol

Indian sites

Start

Recruiting

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

NCT07241390Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease

Eli Lilly and Company

Phase 3

7,140

Ahmedabad, Bangalore, Belagavi, Bhubaneswar, Guntur, Hubli, Hyderabad, Kanpur

2025-12-01

Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-india/condition/chronic-kidney-disease

Query this register directly

GET /api/trials?country=in&status=recruiting&format=json Try it now →

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.